Invention Grant
- Patent Title: Pyridineamine compounds useful as Pim kinase inhibitors
- Patent Title (中): 可用作Pim激酶抑制剂的吡啶胺化合物
-
Application No.: US15166380Application Date: 2016-05-27
-
Publication No.: US09540347B2Publication Date: 2017-01-10
- Inventor: Oleg Vechorkin , Hao Feng , Yun-Long Li , Song Mei , Anlai Wang , Wenyu Zhu , Jincong Zhuo
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D405/14 ; C07D401/04 ; C07D401/12 ; C07D417/14 ; C07D409/14 ; C07D491/048 ; C07D471/04
Abstract:
The present disclosure describes pyridineamine compounds, as well as their compositions and methods of use. The compounds inhibit the activity of the Pim kinases, and are useful in the treatment of diseases related to the activity of Pim kinases including, e.g., cancer and other diseases.
Public/Granted literature
- US20160347735A1 PYRIDINEAMINE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS Public/Granted day:2016-12-01
Information query
